Chief Scientific Officer, Platform
Schrödinger
BROOKLYN, New York
Robert Abel, executive vice president, chief scientific officer, platform, joined Schrödinger in 2009, is responsible for advancing Schrödinger’s computational science platform. He also leads the computational chemistry team within Schrödinger’s drug discovery group. Robert obtained his Ph.D. from Columbia University, where he was awarded NSF and DHS research fellowships. His thesis work with Professor Richard Friesner involved developing methods to quantify the role of solvent in protein-ligand binding. Robert has co-authored multiple patent applications, and continues to publish extensively on a wide variety of topics in computational chemistry.
Disclosure information not submitted.
Keynote: Accelerating Drug Discovery and Development with Advanced Computational Modeling
Wednesday, November 12, 2025
1:30 PM - 2:30 PM CT